A Clinical Trial of TAA06 Injection in Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05190185 |
|
Recruitment Status :
Recruiting
First Posted : January 13, 2022
Last Update Posted : January 13, 2022
|
Sponsor:
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Collaborator:
Department of Immunology, The Fourth Hospital of Hebei Medical University
Information provided by (Responsible Party):
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 1, 2023 |
| Estimated Study Completion Date : | December 1, 2023 |